Galli, Mattia
Occhipinti, Giovanni
Ortega-Paz, Luis
Franchi, Francesco
Rollini, Fabiana
Brugaletta, Salvatore
Capodanno, Davide
Sciarretta, Sebastiano
Angiolillo, Dominick J. https://orcid.org/0000-0001-8451-2131
Article History
Accepted: 13 May 2024
First Online: 29 July 2024
Declarations
:
: The study was not funded.
: M.G. declares that he has no conflicts of interest. F.F. declares that he has received payment as an individual for consulting fee or honoraria from Astra-Zeneca outside the present work and institutional payments for grants from PLx Pharma and The Scott R. MacKenzie Foundation. D.C. reports receiving personal honoraria from Novo Nordisk, Sanofi, and Terumo as well as payment to the institution from Meditronic outside the present work. D.J.A. declares that he has received consulting fees or honoraria from Abbott, Amgen, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, CSL-Behring, Daiichi-Sankyo, Eli Lilly, Faraday, Haemonetics, Janssen, Merck, Novartis, Novo Nordisk, PhaseBio, PLx Pharma, Pfizer, Sanofi, and Vectura outside the present work, as well as research grants to the institution from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Faraday, Gilead, Janssen, Matsutani Chemical Industry Co., Merck, Novartis, Osprey Medical, Renal Guard Solutions, and Scott R. MacKenzie Foundation. G.O., L.O.-P., F.R. S.B. and S.S has no conflicts of interest to disclose.